Final Program

58 SUNDAY • MAY 15
Facilitator:
P188
P189
P190
P191
P192
P193
Facilitator:
P194
P195
P196
P197
P198
P199
V.G. Press, MD, MPH, Chicago, IL
Portable Spirometry in Hospitalized Patients with AECOPD
Predicts Followup Airflow Obstruction/C.H. Loh, K.K. Kannan,
J.A. Ohar, Winston Salem, NC, p.A1518
Standardizing Inhaler Training Across a COPD Care
Management Project/B.W. Carlin, K. Kanel, G. Thomas, S.
Campus, Pittsburgh, PA, p.A1519
The Use of an Spirometry Instructional Program for Healthcare
Providers as a Component of a COPD Care Management
Project/B.W. Carlin, G. Thomas, K. Kanel, Sewickley, PA, p.A1520
Determinants and Patterns of Adherence to Inhaled Therapy by
Patients with Severe Chronic Obstructive Pulmonary Disease
(COPD)/I. Sulaiman, J. Seheult, E. MacHale, D. Seow, F. Rawat, B.
Deering, B. Cushen, M. Mokoka, C. Moran, F. Bolland, R. Costello,
Dublin, Ireland, p.A1521
Examination of Quality Measure Application in Chronic
Obstructive Pulmonary Disease Care in an Internal Medicine
Residents’ Teaching Clinic/R.M. Burkes, U. Chaddha, T.
Mkorombindo, N. Kubiak, K. El-Kersh, R. Cavallazzi, Louisville, KY,
p.A1522
A Chronic Obstructive Pulmonary Disease (COPD) Service
Integrating Community and Hospital Services Can Improve
Patient Care and Reduce Hospital Stays/M. Apps, D. Mukherjee,
S. Abbas, J. Minter, J. Whitfield, S. Field, S. Pearce, M. Haigh, P.
Rosier, B. Hawkes, L. Ateli, S. Webb, D. Carter, S. Barfield, H.
Olympio-anang, P. Bannister, C. Goodrich, J. Finney, K.-A. Keeling,
C. Wigmore, A. Kopacz, J. Downham, I. Young, J. Morgan,
Basildon, United Kingdom, p.A1523
C.H. Martinez, MD, MS, MPH, Ann Arbor, MI
Effect of an Online, Case-Based Educational Intervention in
COPD Among Pulmonologists and Primary Care
Physicians/E.L. Jackson, P. Chatterjee, New York, NY, p.A1524
A Telemedicine-Based Disease Management Program for Daily
COPD Symptom Reporting Reduces Hospitalizations, Hospital
Length of Stay, and Emergency Room Visits/R.N. Criner, M.R.
Jacobs, A.J. Criner, A. Rastogi, S.S. Strasburger, S.S. Cheng, M.J.
Markus, G. Criner, Philadelphia, PA, p.A1525
Clinical Features and Discharge Characteristics of Patients
Readmitted Within 30 Days Following Index Admission for
COPD Exacerbation at Yale-New Haven Hospital/S. Farasat,
J.D. Possick, C.L. Rochester, Derby, CT, p.A1526
Factors Affecting the 30 Day Readmission Rate for Chronic
Obstructive Pulmonary Disease(COPD) in a Tertiary Care
Community Hospital/B. Diede, D. Sese, M. Nasser, R. Rosario, T.
McNatt, A. Diwakar, Akron, OH, p.A1527
Impact of Continuous Positive Airway Pressure Use on
Hospitalization Rates in Medicare Beneficiaries with
Coexisting COPD and Obstructive Sleep Apnea: The Overlap
Syndrome/G.P. Singh, W. Zhang, Y.F. Kuo, R. Sultana, G.
Sharma, Galveston, TX, p.A1528
BiPAP Use in Type Two Respiratory Failure: A Predictor of
Mortality?/M. Quinn, R.J. Fahy, Dublin, Ireland, p.A1529
Facilitator:
J.K. Quint, MBBS, PhD, London, United Kingdom
P200 Effects of Outside Environment on the Performance of the 6
Minute Walk Test in COPD/P. Patel, S. Paredes, M. Campos,
Miami, FL, p.A1530
P201
P202
P203
P204
P205
P206
P207
A42
Mindfulness Based Stress Reduction for Patients with Chronic
Lung Disease/N.-C. Liang, E.C. Bernadas, R. Jen, Y. Li, A.
Minassian, A. Malhotra, A. Ries, S. Hickman, San Diego, CA,
p.A1531
Depression, Anxiety, and Cognitive Impairment: Risk of
Exacerbations in Chronic Obstructive Pulmonary Disease/N.
Tobey, H.Q. Nguyen, K.C. Pike, S. Borson, Z. Chen, J. Lee, V.S.
Fan, Seattle, WA, p.A1532
Depressive Symptoms and Lung Function and Percent
Emphysema in the Multi-Ethnic Study of Atherosclerosis
(MESA) Lung Study/C. Almonte, C. Lo Cascio, H.F. Armstrong, M.
Parikh, J.E. Schwartz, J.H.M. Austin, K. Watson, V.S. Fan, K.E.
Killeen, R.G. Barr, New York, NY, p.A1533
The Impact of Incorrect Coding on a Medicare Bundled
Payment for Care Improvement Initiative (BPCI) for COPD
Exacerbations/S. Khanijo, A. Palkar, A. Cohen, R. Ramdeo, A.
Eichorn, Z. Brown, G.N. Lisker, New Hyde Park, NY, p.A1534
Clinical Characteristics and Outcomes of COPD Patients
Included and Excluded from a Medicare Bundled Payment
Care Initiative/T.M. Parekh, S.P. Bhatt, J.M. Wells, D.P.
Kirkpatrick, J.K. Nichols, C.C. Blackburn, A. Westfall, M. Mugavero,
J. Willig, M.T. Dransfield, Birmingham, AL, p.A1535
How Do Symptoms and Comorbidities Affect Healthcare Costs
in Patients with COPD? Results from the New German
COSYCONET Cohort/M.E. Wacker, R.A. Jorres, H. Schulz, J.
Heinrich, S. Karrasch, A. Karch, A. Koch, R. Leidl, C. Vogelmeier,
R. Holle, Neuherberg, Germany, p.A7787
Longitudinal Association of Percent Emphysema and
Progression of Coronary Artery Calcium (CAC): The
Multi-Ethnic Study of Atherosclerosis (MESA) Lung
Study./M.E. Gomez Almonte, M.J. Budoff, T. Di Vitantonio, E.A.
Hoffman, J. Kaufman, M. Parikh, A. Gassett, E.D. Michos, R.G.
Barr, New York, NY, p.A7788
THEMATIC POSTER SESSION
AUTOIMMUNE MYOSITIS, ANTISYNTHETASE,
SCLERODERMA, AND IPAF
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area L, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P1219
A. Fischer, MD, Denver, CO
Clinical and Radiological Predictor of Polymyositis and
Dermatomyositis Associated Interstitial Lung Disease/T.
Kishaba, H. Nagano, Y. Nei, S. Yamashiro, Uruma, Japan, p.A1536
ATS 2016 • San Francisco